
FDA Alerts Pet Owners About Potential for Neurologic Adverse Events Associated with Certain Flea & Tick Products
The U.S. Food and Drug Administration is alerting pet owners and veterinarians to be aware of the potential for neurologic adverse events in dogs and cats when treated with drugs that are in the isoxazoline class.